Gardasil
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Human Papillomavirus Infection
Conditions
Human Papillomavirus Infection
Trial Timeline
Oct 1, 2009 → Aug 1, 2011
NCT ID
NCT00925288About Gardasil
Gardasil is a approved stage product being developed by Merck for Human Papillomavirus Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT00925288. Target conditions include Human Papillomavirus Infection.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (8)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04022148 | Pre-clinical | UNKNOWN |
| NCT01432574 | Phase 2 | Completed |
| NCT01741012 | Phase 1 | Completed |
| NCT01338051 | Phase 1 | Completed |
| NCT00925288 | Approved | Completed |
| NCT01133509 | Pre-clinical | UNKNOWN |
| NCT00786409 | Pre-clinical | Completed |
| NCT00666107 | Pre-clinical | UNKNOWN |
Competing Products
20 competing products in Human Papillomavirus Infection